Corrigendum: Regulatory Framework for Advanced Therapy Medicinal Products in Europe and United States (Frontiers in Pharmacology, (2019), 10, 10.3389/fphar.2019.00921)

Carolina Iglesias-Lopez; Antonia Agustí; Mercè Obach; Antonio Vallano

doi:10.3389/fphar.2020.00766

Corrigendum: Regulatory Framework for Advanced Therapy Medicinal Products in Europe and United States (Frontiers in Pharmacology, (2019), 10, 10.3389/fphar.2019.00921)

Carolina Iglesias-Lopez, Antonia Agustí, Mercè Obach^*, Antonio Vallano

^*Corresponding author for this work

Department of Pharmacology, Therapeutics and Toxicology

Research output: Contribution to journal › Article › Research › peer-review

Abstract

In the original article, there was an error. In the specified paragraph, the word “latter” and “former” should be interchanged. A correction has been made to the Regulatory Framework for the Classification of Advanced Therapies section, paragraph 8:

Original language	American English
Article number	766
Journal	Frontiers in Pharmacology
Volume	11
DOIs	https://doi.org/10.3389/fphar.2020.00766
Publication status	Published - 25 May 2020

Keywords

biological products
biological therapy
cell- and tissue-based therapy
Europe
genetic therapy
legislation and jurisprudence
tissue engineering
United States Food and Drug Administration

Access to Document

10.3389/fphar.2020.00766

Cite this

@article{098ba6be7d9e4d3196b792118787988b,

title = "Corrigendum: Regulatory Framework for Advanced Therapy Medicinal Products in Europe and United States (Frontiers in Pharmacology, (2019), 10, 10.3389/fphar.2019.00921)",

abstract = "In the original article, there was an error. In the specified paragraph, the word “latter” and “former” should be interchanged. A correction has been made to the Regulatory Framework for the Classification of Advanced Therapies section, paragraph 8:",

keywords = "biological products, biological therapy, cell- and tissue-based therapy, Europe, genetic therapy, legislation and jurisprudence, tissue engineering, United States Food and Drug Administration",

author = "Carolina Iglesias-Lopez and Antonia Agust{\'i} and Merc{\`e} Obach and Antonio Vallano",

year = "2020",

month = may,

day = "25",

doi = "10.3389/fphar.2020.00766",

language = "Ingl{\'e}s estadounidense",

volume = "11",

journal = "Frontiers in Pharmacology",

issn = "1663-9812",

}

Corrigendum : Regulatory Framework for Advanced Therapy Medicinal Products in Europe and United States (Frontiers in Pharmacology, (2019), 10, 10.3389/fphar.2019.00921). / Iglesias-Lopez, Carolina; Agustí, Antonia; Obach, Mercè; Vallano, Antonio.

In: Frontiers in Pharmacology, Vol. 11, 766, 25.05.2020.

Research output: Contribution to journal › Article › Research › peer-review

TY - JOUR

T1 - Corrigendum

T2 - Regulatory Framework for Advanced Therapy Medicinal Products in Europe and United States (Frontiers in Pharmacology, (2019), 10, 10.3389/fphar.2019.00921)

AU - Iglesias-Lopez, Carolina

AU - Agustí, Antonia

AU - Obach, Mercè

AU - Vallano, Antonio

PY - 2020/5/25

Y1 - 2020/5/25

N2 - In the original article, there was an error. In the specified paragraph, the word “latter” and “former” should be interchanged. A correction has been made to the Regulatory Framework for the Classification of Advanced Therapies section, paragraph 8:

AB - In the original article, there was an error. In the specified paragraph, the word “latter” and “former” should be interchanged. A correction has been made to the Regulatory Framework for the Classification of Advanced Therapies section, paragraph 8:

KW - biological products

KW - biological therapy

KW - cell- and tissue-based therapy

KW - Europe

KW - genetic therapy

KW - legislation and jurisprudence

KW - tissue engineering

KW - United States Food and Drug Administration

UR - http://www.scopus.com/inward/record.url?scp=85086085110&partnerID=8YFLogxK

U2 - 10.3389/fphar.2020.00766

DO - 10.3389/fphar.2020.00766

M3 - Artículo

C2 - 32523535

AN - SCOPUS:85086085110

VL - 11

JO - Frontiers in Pharmacology

JF - Frontiers in Pharmacology

SN - 1663-9812

M1 - 766

ER -

Corrigendum: Regulatory Framework for Advanced Therapy Medicinal Products in Europe and United States (Frontiers in Pharmacology, (2019), 10, 10.3389/fphar.2019.00921)

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this